Search Results - "Leuchte, H H"

Inhalation of vasoactive intestinal peptide in pulmonary hypertension by Leuchte, H. H, Baezner, C, Baumgartner, R. A, Bevec, D, Bacher, G, Neurohr, C, Behr, J

“…Pulmonary hypertension (PH) leads to an increased right ventricular workload, cardiac failure and death. In idiopathic pulmonary arterial hypertension (PAH)…”
Get full text

Treatment Goals of Pulmonary Hypertension by McLaughlin, Vallerie V., MD, Gaine, Sean Patrick, MD, PhD, Howard, Luke S., DPhil, Leuchte, Hanno H., MD, Mathier, Michael A., MD, Mehta, Sanjay, MD, Palazzini, Massimillano, MD, Park, Myung H., MD, Tapson, Victor F., MD, Sitbon, Olivier, MD, PhD

“…With significant therapeutic advances in the field of pulmonary arterial hypertension, the need to identify clinically relevant treatment goals that correlate…”
Get full text

Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease by Leuchte, Hanno H, Baumgartner, Rainer A, Nounou, Michal El, Vogeser, Michael, Neurohr, Claus, Trautnitz, Michael, Behr, Juergen

“…The detection of pulmonary hypertension in patients with chronic lung disease has prognostic implications. The brain natriuretic peptide (BNP) has been…”
Get full text

Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension by Leuchte, Hanno H, Neurohr, Claus, Baumgartner, Rainer, Holzapfel, Michael, Giehrl, Wolfgang, Vogeser, Michael, Behr, Jurgen

“…Pulmonary hypertension (PH) can develop in lung fibrosis, and contributes to increased morbidity and mortality. Noninvasive parameters in the evaluation of PH…”
Get full text

The Potential of Biomarkers in Pulmonary Arterial Hypertension by Cracowski, Jean-Luc, MD, PhD, Leuchte, Hanno H., MD

“…Effective management of patients with pulmonary arterial hypertension (PAH) requires comprehensive prognostic evaluation in order to determine optimal…”
Get full text

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension by Leuchte, Hanno H., Holzapfel, Michael, Baumgartner, Rainer A., Ding, Isabelle, Neurohr, Claus, Vogeser, Michael, Kolbe, Tilman, Schwaiblmair, Martin, Behr, Jürgen

“…The aim of this study was to investigate the potential role of brain natriuretic peptide (BNP) levels in the assessment of functional status and right heart…”
Get full text

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension by Hoeper, M. M, Leuchte, H, Halank, M, Wilkens, H, Meyer, F. J, Seyfarth, H. J, Wensel, R, Ripken, F, Bremer, H, Kluge, S, Hoeffken, G, Behr, J

“…Addition of inhaled iloprost to bosentan may have beneficial effects in patients with idiopathic pulmonary arterial hypertension (IPAH). A multicentre, open,…”
Get full text

N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension by Leuchte, Hanno H, El Nounou, Michal, Tuerpe, Juergen Christian, Hartmann, Bertram, Baumgartner, Rainer A, Vogeser, Michael, Muehling, Olaf, Behr, Jürgen

“…N-terminal pro-brain natriuretic peptide (NT-proBNP) is a byproduct of the brain natriuretic peptide (BNP) that was shown to be of prognostic value in…”
Get more information

Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension by Leuchte, Hanno H, Holzapfel, Michael, Baumgartner, Rainer A, Neurohr, Claus, Vogeser, Michael, Behr, Jürgen

“…Pulmonary arterial hypertension (PAH) leads to substantial morbidity and mortality. Noninvasive parameters in the follow-up assessment of PAH could be helpful…”
Get more information

Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via coapplication of a neutral endopeptidase 24.11 inhibitor by Leuchte, Hanno H, Prechtl, Christoph, Callegari, Jens, Meis, Tobias, Haziraj, Shani, Bevec, Dorian, Behr, Jürgen

“…A deficiency of the pulmonary vasodilative vasoactive intestinal peptide (VIP) has been suggested to be involved in the pathophysiology of pulmonary…”
Get more information

Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis by Leuchte, Hanno H, Mernitz, Philip, Baezner, Carlos, Baumgartner, Rainer A, von Wulffen, Werner, Neurohr, Claus, Behr, Juergen

“…Idiopathic pulmonary fibrosis (IPF) is a progressive disease, leading to substantial physical impairment. The distance walked in 6 min (6MWD) is a measure of…”
Get more information

Current Aspects of Definition and Diagnosis of Pulmonary Hypertension by Lange, T J, Borst, M, Ewert, R, Halank, M, Klose, H, Leuchte, H, Meyer, F J, Seyfarth, H-J, Skowasch, D, Wilkens, H, Held, M

“…At the 6th World Symposium on Pulmonary Hypertension (WSPH), which took place from February 27 until March 1, 2018 in Nice, scientific progress over the past 5…”
Get more information

Differential Diagnosis of Pulmonary Hypertension Using the Example of Collagenosis-associated PAH in the Context of Chronic Lung and Left Heart Disease by Leuchte, H H, Halank, M, Held, M, Borst, M, Ewert, R, Klose, H, Lange, T J, Meyer, F J, Skowasch, D, Wilkens, H, Seyfarth, H-J

“…Pulmonary hypertension (PH) can be diagnosed in the context of connective tissue diseases (CTD) as well as in elderly patients with multiple comorbidities. A…”
Get more information

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension by Leuchte, Hanno H, Schwaiblmair, Martin, Baumgartner, Rainer A, Neurohr, Claus F, Kolbe, Tilman, Behr, Jürgen

“…Different vasodilators and different routes of application are used for the treatment of primary pulmonary hypertension (PPH). Recently, sildenafil, a…”
Get more information

Usefulness of Exhaled Nitric Oxide to Guide Risk Stratification for Bronchiolitis Obliterans Syndrome After Lung Transplantation by Neurohr, C., Huppmann, P., Leuschner, S., von Wulffen, W., Meis, T., Leuchte, H., Ihle, F., Zimmermann, G., Baezner, C., Hatz, R., Winter, H., Frey, L., Ueberfuhr, P., Bittmann, I., Behr, J.

“…The aim of this study was to assess fractional exhaled nitric oxide (FeNO) for the early diagnosis of bronchiolitis obliterans syndrome (BOS) after lung…”
Get full text

Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016 by Hoeper, M M, Apitz, C, Grünig, E, Halank, M, Ewert, R, Kaemmerer, H, Kabitz, H-J, Kähler, C, Klose, H, Leuchte, H, Ulrich, S, Olsson, K M, Distler, O, Rosenkranz, S, Ghofrani, H A

“…The 2015 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension are also valid for Germany. The guidelines contain detailed recommendations…”
Get more information

Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016 by Leuchte, H H, Ten Freyhaus, H, Gall, H, Halank, M, Hoeper, M M, Kaemmerer, H, Kähler, C, Riemekasten, G, Ulrich, S, Schwaiblmair, M, Ewert, R

“…The 2015 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension are also valid for Germany. The guidelines contain detailed information about…”
Get more information

Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial by HOEPER, Marius M, HALANK, Michael, WILKENS, Heinrike, GÜNTHER, Andreas, WEIMANN, Gerrit, GEBERT, Irmingard, LEUCHTE, Hanno H, BEHR, Jürgen

“…We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension…”
Get full text

Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics by Walmrath, D, Grimminger, F, Pappert, D, Knothe, C, Obertacke, U, Benzing, A, Gunther, A, Schmehl, T, Leuchte, H, Seeger, W

“…The aim of the present study was to investigate the feasibility and efficacy of bronchoscopic surfactant administration in a noncontrolled multicentre study in…”
Get full text

Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort Study by Valerio, Luca, Barco, Stefano, Jankowski, Marius, Rosenkranz, Stephan, Lankeit, Mareike, Held, Matthias, Gerhardt, Felix, Bruch, Leonhard, Ewert, Ralf, Faehling, Martin, Freise, Julia, Ghofrani, Hossein-Ardeschir, Grünig, Ekkehard, Halank, Michael, Hoeper, Marius M, Klok, Frederikus A, Leuchte, Hanno H, Mayer, Eckhard, Meyer, F Joachim, Neurohr, Claus, Opitz, Christian, Schmidt, Kai-Helge, Seyfarth, Hans-Jürgen, Trudzinski, Franziska, Wachter, Rolf, Wilkens, Heinrike, Wild, Philipp S, Konstantinides, Stavros V

“…Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE). What are the kinetics and…”
Get full text